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Purpose: To catalog mutations that underlie retinitis pigmentosa (RP) in Saudi Arabia using a representative sample.
Methods: Fifty-two patients with RP were recruited and their homozygosity mapping, with or without linkage analysis,
was used to suggest the causative genes followed by bidirectional sequencing.
Results: Mutations were identified in 94% of our study cohort, including seven that were novel.
Conclusions: Homozygosity mapping is an extremely robust approach in the study of retinitis pigmentosa in the setting
of high rates of consanguinity. BBS3 mutations can rarely present as nonsyndromic RP.
The retina is an elaborate eye structure that is responsible
for transforming light energy into chemical and electrical
energy, which the brain decodes to produce normal visual
perception [1]. Photoreceptors play a key role in this complex
process,  and  functional  or  structural  defects  in  these
specialized receptors adversely affect retinal function. The
nonspecific term “retinal dystrophy” has long been used as a
clinical descriptor of hereditary conditions characterized by
progressive  loss  of  photoreceptors  associated  with  an
abnormal  appearance  of  the  retina  [2].  Some  of  these
conditions appear specifically to affect the photoreceptors
concerned  with  color  vision  (cones),  while  others  are
characterized by more significant involvement of dark vision
photoreceptors  (rods).  Still  others  affect  photoreceptors
indirectly by causing progressive damage to the supporting
retinal  pigment  epithelium  [3].  Retinitis  pigmentosa  (RP)
represents the most common form of retinal dystrophies, and
while it preferentially affects rod function, cone function is
also affected in advanced cases [4]. The age of onset is also
variable, with some patients presenting at birth (this is usually
referred to as Leber congenital amaurosis, or LCA) and others
presenting later in childhood or even in adulthood [5]. With
more than 51 genes and loci known to be involved in the
pathogenesis of RP, the delineation of the underlying genetic
defect  represents  a  major  challenge  in  establishing  the
molecular diagnosis for these patients. However, identifying
the  mutation  is  of  great  clinical  utility  because  it  is  a
prerequisite  to  key  preventive  measures  such  as  prenatal
diagnosis  and  preimplantation  genetic  diagnosis.
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Furthermore, with the recent advances in gene therapy for
some cases of RP [6,7], there is increasing interest among
patients to know their mutation, since it might determine their
eligibility for ongoing and future clinical trials relevant to their
specific gene mutation.
While genetic defects that cause RP are known to follow
all  modes  of  Mendelian  inheritance,  autosomal  recessive
forms of RP are estimated to contribute 50%–60% to the
overall mutation pool of the disease [8]. Consanguinity is
known to increase the frequency of recessive disorders since
it renders part of the genome homozygous by descent, which
increases  the  likelihood  of  the  appearance  of  recessive
ancestral  mutations  in  the  homozygous  state  [9,10].  We
hypothesized that autosomal recessive RP will account for the
majority  of  cases  in  the  highly  consanguineous  Saudi
population.  Consequently,  mapping  of  blocks  of
homozygosity in RP patients from Saudi Arabia could serve
as a shortcut to the identification of the likely candidate genes,
as  an  alternative  to  the  massive  sequencing  effort  that  is
usually needed to make the molecular diagnosis in patients
with this genetically heterogeneous disorder. In this study, the
largest  to  date  on  Saudi  RP  patients,  we  show  that
homozygosity mapping is indeed a powerful tool for the rapid
and efficient identification of the causative mutations of this
condition.
METHODS
Human  subjects:  Patients  with  RP  were  identified  using
established ophthalmological criteria that are based on the
gross appearance of the retina and on a detailed functional
assessment  [11].  With  the  exception  of  patients  with
syndromic forms, all referred patients with RP were enrolled
in this study regardless of the age of onset. A written consent
form  was  signed  by  all  participants  and/or  their  legal
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2464guardians. Thorough family histories were obtained from all
patients, who were accordingly categorized as either sporadic
or familial. Patients were recruited through King Khaled Eye
Specialist Hospital and King Faisal Specialist Hospital and
Research Center. This study was approved by the Institutional
Review Board at King Faisal Specialist Hospital and Research
Center (RAC#2070023) in accordance with the Declaration
of Helsinki.
DNA and RNA extraction: DNA was extracted from whole
blood using standard protocol. Blood was also collected for
RNA extraction in PAXGene tubes (Qiagen, Germantown,
MD), whenever possible, from all sporadic cases and from at
least the index in familial cases.
Genotyping: Genome-wide genotypes were obtained using an
Affymetrix  SNP  250K  Chip  platform  (Affymetrix,  Santa
Clara, CA) following the manufacturer’s instructions. Blocks
of homozygosity were identified using either the Affymetrix®
Genotyping  Console™  (Affymetrix)  or  Copy  Number
Analyzer for GeneChip® arrays, Version 3.0 (CNAG, Tokyo,
Japan) [12].
Linkage analysis: When three or more affected individuals
were identified in one family, linkage analysis was performed
on  the  SNP  genotypes  using  the  Allegro  component  of
EasyLinkage software [13].
Mutation analysis: Genes suggested by linkage analysis and/
or homozygosity mapping were PCR-amplified using primers
that covered the entire coding sequence, as well as the flanking
intronic sequences. PCR amplification was performed on a
thermocycler  (DNA  Engine  Tetrad.  MJ  Research,  Inc.,
Waltham, MA) in a total volume of 25 µl. PCR primers as
well as reaction conditions are available upon request. PCR
amplicons were submitted for bidirectional sequencing using
an  Amersham  ET  Dye  Terminator  Cycle  Sequencing  Kit
(Amersham  Biosciences,  Piscataway,  NJ)  following  the
manufacturer’s  instructions.  Sequence  analysis  was
performed  using  the  SeqManII  module  of  the  Lasergene
(DNA  Star  Inc.,  Madison,  WI)  software  package,  with  a
normal sequence used for comparison. All missense mutations
were  confirmed  by  screening  at  least  100  Saudi  control
individuals and by checking for conservation across different
species.
RESULTS
Human  subjects:  We  were  able  to  enroll  52  patients
representing 6 sporadic and 11 familial cases. Only three
patients  (one  family)  had  a  family  history  suggestive  of
dominant inheritance, and no patients appeared from their
histories to have the X-linked form of RP. Table 1 summarizes
the families enrolled and their phenotypes (LCA versus RP
with onset later in life).
Linkage analysis: Eight families had three or more affected
members, and were deemed suitable for traditional linkage
analysis. Family DGU-F13 was suggestive of an autosomal-
dominant pattern of inheritance. Despite the limited number
of meiotic recombinants (three affected and four unaffected
in two generations), we were able to generate a few linkage
peaks, one of which overlapped with the CRX1 locus. Of the
remaining seven families, only two (DGU-F4 and DGU-F5)
gave a definitive single linkage peak with a significant LOD
score (>3.5) corresponding to the TULP1 locus. In contrast,
in the remaining five families, multiple linkage peaks were
obtained (averaging three peaks for LOD scores of 2–3), and
subsequent analysis was only possible with the aid of CNAG
(see below). In all these families, mutation analysis confirmed
the presence of pathogenic mutations in the linkage loci (see
below). Surprisingly, Family DGU-F15 was found to link to
the BBS3 locus even though the phenotype was clearly that of
nonsyndromic retinitis pigmentosa.
Homozygosity mapping: After the exclusion of Family DGU-
F13 (which was autosomal dominant), Families DGU-F4 and
F5 (for which definitive one-linkage peaks were obtained),
and the 10 patients for whom targeted mutation analysis was
positive (see below), all remaining patients (n=25) had their
DNA genotyped to determine their blocks of homozygosity.
Consistent with the fact that 94% of these patients came from
consanguineous families, multiple blocks of homozygosity
were usually seen for each patient (averaging 3.4). These
averaged 33 Mb in size, ranging from 5 to 40 Mb. With the
exception of one sporadic case (DGU-F17), at least one of
these regions overlapped with a locus known to be involved
in RP.
Mutation  analysis:  Table  1  summarizes  all  mutations
identified in the course of this study. In all, we have identified
the causative mutation in 51 out of our 52 patients, and seven
of these mutations were novel (Figure 1). None of the novel
missense  mutations  was  found  in  a  panel  of  at  least  100
ethnically  matched  controls  (≥200  chromosomes),  and  all
were found to fully segregate with the disease, whenever
applicable  i.e.,  in  families  with  more  than  one  affected
member. Furthermore, strong conservation across species was
demonstrated for all of them (Figure 2).
Linkage  to  TULP1,  which  was  identified  by  linkage
analysis  in  Families  DGU-F4  and  F5  (14  patients)  was
followed  up  by  mutation  analysis,  which  confirmed  the
presence  of  a  pathogenic  mutation  (Figure  1).  Haplotype
analysis confirmed the ancestral nature of this mutation. This
was the first mutation identified in this study so to examine
the  contribution  of  this  founder  mutation  to  the  overall
mutation pool, we have undertaken targeted mutation analysis
of  all  of  our  samples  (except  for  Family  DGU-F13  with
autosomal dominant inheritance). This approach allowed us
to identify 10 additional patients representing five families
(DGU-F3, F6, F7, F8, F9, and F10). For all the remaining
patients (n=25), we systemically screened for mutations in
known RP genes that reside in blocks of homozygosity. The
number of genes suggested by our homozygosity mapping
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2466ranged from 1 to 10 per patient. The average number of genes
sequenced per patient was two. Pathological mutations were
identified in all but one patient (Table 1).
Notably,  our  list  of  novel  mutations  included  one  in
MERTK, one of the least frequent causes of RP [14,15]. The
highly surprising finding of a linkage in Family DGU-F15 was
pursued with mutation analysis of BBS3, which revealed a
novel missense mutation. Based on this finding, the family
was  called  back  for  a  comprehensive  clinical  genetics
evaluation,  which  confirmed  the  complete  lack  of  any
apparent or visceral manifestation of Bardet-Biedl syndrome
other than retinitis pigmentosa (unpublished).
DISCUSSION
Recently,  a  study  on  the  genetics  of  Leber  congenital
amaurosis in 38 Saudi families [16] reported 24% mutation
detection. While our study cohort was smaller (17 families),
we  believe  the  remarkably  higher  mutation  detection  rate
found in the current study can be attributed to the difference
in methodology. Li and colleagues selectively screened for
mutations in 13 known LCA genes by direct sequencing. Our
Figure  1.  Summary  of  the  novel
mutations  identified  in  this  study.
Simplified pedigrees are shown for each
of the families (circle for female, square
for male, white for unaffected, and black
for affected). Below each pedigree, a
sequence  chromatogram  is  shown  for
the  corresponding  mutation,  with  a
wildtype tracing for comparison (arrow
indicates the position of the mutation on
the chromatogram).
Figure 2. Analysis of the conservation
level  of  the  missense  mutations
identified  in  this  study.  For  each
missense mutation, a panel of orthologs
from different organisms is shown to
demonstrate  the  conservation  of  the
involved residue across species, which
suggests that a change of that residue
may  adversely  affect  the  protein
function.
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2467approach,  on  the  other  hand,  was  not  biased  toward  a
particular group of genes. The very large network of referring
physicians from all parts of the country, as well as the largest
specialized  eye  hospital  (King  Khaled  Eye  Specialist
Hospital) makes it likely that our cohort was a representative
sample of the RP population in Saudi Arabia. Our group has
previously shown how consanguinity can override founder
effect and allow for greater genetic and allelic heterogeneity
than expected for populations characterized historically by
limited mixing of their genetic pool, as is the case for the
population of Saudi Arabia [17]. Indeed, the results of our
analysis show that with the exception of the TULP1 mutation,
our nine mutations, seven of which were novel, are private
mutations that are only seen in isolated familial or sporadic
cases. Of note is that the phenotype associated with the novel
mutations  (LCA  versus  RP  with  onset  later  in  life)  is
consistent with previously published mutations in those genes.
Remarkably, of the 16 families for whom a mutation was
assigned, 15 (93.75%) had autosomal recessive mutations that
explained  their  condition.  This  extraordinary  contribution
from the autosomal recessive category to the overall disease
pool was remarkably higher than what has previously been
published  on  the  genetics  of  this  condition  [8].  This  is
consistent with the fact that 92% of our patients come from
consanguineous families, a much higher percentage than the
national average of 56% [18]. This should not be viewed as a
consequence of the bias of our homozygosity approach, which
can  only  aid  in  the  identification  of  recessively  acting
mutations. Indeed, this percentage was calculated based on all
patients (n=52) who were enrolled regardless of the apparent
mode  of  inheritance.  One  may  argue  that  patients  with
recessive mutations are more likely to be referred, compared
to patients with de novo dominant mutations as a result of their
more conspicuous familial clustering. Indeed, only 11% of our
study’s patients with recessive mutations were sporadic and
without a family history. However, the latter finding is of
particular relevance to the design of testing algorithms in the
future, since it suggests that even in the absence of family
history, Saudi RP patients are still likely to have the autosomal
recessive  form  of  the  disease.  This  makes  homozygosity
mapping a particularly appealing approach, as it is very likely
to aid in molecular diagnosis in the overwhelming majority of
Saudi RP patients. We believe that the clinical utility of this
approach is currently superior to that of other strategies. For
example,  the  prioritization  of  genetic  testing  based  on
frequency data are still not applicable in Saudi Arabia, since
such data do not exist yet. Indeed, this study, given its size,
falls short of addressing this, and more studies will need to be
conducted in the future, to more comprehensively catalog the
mutational spectrum of this condition in Saudi Arabia. For the
same reason, the targeted mutation screening approach is not
very practical at the moment. Additionally, as we have shown
in previous work [17], we expect the majority of mutations to
be private mutations, which limits their generalizability. Very
recently,  Bergen  et  al.  [19]  have  suggested  the  use  of  a
sequencing chip that sequences genes known to cause retinal
dystrophy. While this approach is probably very practical in
outbred  populations,  we  believe  that,  in  highly
consanguineous populations, homozygosity mapping offers
significant cost savings over this approach that involves the
routine generation of 400 PCR amplicons for each patient
sample [19].
In summary, our study represents the largest molecular
study of RP (both LCA and delayed onset) in Saudi Arabia to
date.  Autosomal  recessive  forms  account  for  the
overwhelming  majority  of  RP  in  our  population,  which
particularly suits it for homozygosity mapping, a powerful,
high-throughput approach with significant savings in time and
cost. Our analysis adds seven novel mutations to the list of
mutations  in  the  known  RP  genes,  including  the  highly
unusual mutation in BBS3 in a patient with nonsyndromic
retinitis pigmentosa. The clinical utility of this study will be
further  enhanced  by  our  ongoing  effort  to  recruit  more
families for molecular testing.
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